Ayumi Taguchi

3.1k total citations · 1 hit paper
103 papers, 1.7k citations indexed

About

Ayumi Taguchi is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Ayumi Taguchi has authored 103 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 33 papers in Obstetrics and Gynecology and 31 papers in Reproductive Medicine. Recurrent topics in Ayumi Taguchi's work include Endometrial and Cervical Cancer Treatments (23 papers), Cervical Cancer and HPV Research (19 papers) and Endometriosis Research and Treatment (18 papers). Ayumi Taguchi is often cited by papers focused on Endometrial and Cervical Cancer Treatments (23 papers), Cervical Cancer and HPV Research (19 papers) and Endometriosis Research and Treatment (18 papers). Ayumi Taguchi collaborates with scholars based in Japan, United States and Italy. Ayumi Taguchi's co-authors include Yutaka Osuga, Tomoyuki Fujii, Kei Kawana, Osamu Wada‐Hiraike, Katsutoshi Oda, Kaori Koga, Aki Yamashita, Katsuyuki Adachi, Yoko Urata and Tomoko Makabe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ayumi Taguchi

95 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

2024 76 citations Egbert F. Smit, Enriqueta Felip et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Ayumi Taguchi

Since Specialization

Citations

This map shows the geographic impact of Ayumi Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayumi Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayumi Taguchi more than expected).

Fields of papers citing papers by Ayumi Taguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayumi Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayumi Taguchi. The network helps show where Ayumi Taguchi may publish in the future.

Co-authorship network of co-authors of Ayumi Taguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ayumi Taguchi. A scholar is included among the top collaborators of Ayumi Taguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayumi Taguchi. Ayumi Taguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of human papillomavirus types on uterine cervical neoplasia 2024 ·Journal of obstetrics and gynaecology research ·Ayumi Taguchi, (unknown), (unknown), (unknown), Akira Kawata, Yuichiro Miyamoto, (unknown), Kenbun Sone, Yasushi Hirota, Yutaka Osuga	1
2	Trastuzumab deruxtecan (T-DXd) in patients with HER2-mutant metastatic non–small cell lung cancer (mNSCLC): Final analysis results of DESTINY-Lung02. 2024 ·Journal of Clinical Oncology ·Pasi A. Jänne, (unknown), Toshio Kubo, Kiichiro Ninomiya, Sang‐We Kim, David Planchard, Myung‐Ju Ahn, Egbert F. Smit, Adrianus J. de Langen, M. Pérol, Elvire Pons‐Tostivint, Silvia Novello, Hidetoshi Hayashi, Junichi Shimizu, Dong‐Wan Kim, Kaline Pereira, (unknown), Ayumi Taguchi, Yingkai Cheng, Kōichi Goto	4
3	Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial breakdown → 2024 ·The Lancet Oncology ·Egbert F. Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz‐Ares, Jose M. Pacheco, Bob T. Li, David Planchard, Christina S. Baik, Yasushi Goto, Haruyasu Murakami, Andreas Saltos, Kaline Pereira, Ayumi Taguchi, Yingkai Cheng, (unknown), Wenqin Feng, Zenta Tsuchihashi, Pasi A. Jänne	76
4	510MO Trastuzumab deruxtecan (T-DXd) in Asian patients (Pts) with human epidermal growth factor receptor 2 (HER2; ERBB2)-mutant (HER2m) metastatic non-small cell lung cancer (mNSCLC): Subgroup analysis of DESTINY–Lung02 (DL-02) 2023 ·Annals of Oncology ·Yasushi Goto, Kōichi Goto, Toshio Kubo, Kiichiro Ninomiya, S-W. Kim, M-J. Ahn, Kazuhiko Nakagawa, Hidetoshi Hayashi, Junichi Shimizu, Dongwook Kim, (unknown), (unknown), K.H. Lee, (unknown), Kaline Pereira, Ayumi Taguchi, Ahmed Ali, (unknown), (unknown), Pasi A. Jänne	2
5	MA13.10 Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer: Primary Results of DESTINY-Lung02 2023 ·Journal of Thoracic Oncology ·Pasi A. Jänne, Yasushi Goto, Toshio Kubo, Kiichiro Ninomiya, (unknown), (unknown), Myung‐Ju Ahn, Egbert F. Smit, Adrianus J. de Langen, M. Pérol, (unknown), Silvia Novello, Hidetoshi Hayashi, Junichi Shimizu, D.-W. Kim, (unknown), Fang Cheng, Ayumi Taguchi, Yun Cheng, Kōichi Goto	2
6	The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma 2023 ·Journal of Gynecologic Oncology ·(unknown), Kenbun Sone, Katsuhiko Noda, (unknown), Shimpei Kato, (unknown), Ayumi Taguchi, Ryo Kurokawa, Yutaka Osuga	3
7	Upregulation of autotaxin by oxidative stress via Nrf2 activation: A novel insight into the compensation mechanism in preeclamptic placenta 2023 ·Journal of Reproductive Immunology ·(unknown), Takeshi Nagamatsu, Makoto Kurano, (unknown), Ayumi Taguchi, (unknown), Mari Ichinose, Keiichi Kumasawa, Takayuki Iriyama, Tomoyuki Fujii, Yutaka Yatomi, Yutaka Osuga	3
8	Evolution of a surgical system using deep learning in minimally invasive surgery (Review) 2023 ·Biomedical Reports ·Kenbun Sone, (unknown), (unknown), Ayumi Taguchi, Yuichiro Miyamoto, Mayuyo Mori, Takayuki Iriyama, Osamu Wada‐Hiraike, Yutaka Osuga	9
9	Impact of Chronic Exposure to Endometriosis on Perinatal Outcomes: Establishment of a Mouse Model 2022 ·Biomedicines ·(unknown), Kaori Koga, (unknown), Keiichi Kumasawa, (unknown), Ayumi Taguchi, Tomoko Makabe, Arisa Takeuchi, Gentaro Izumi, Masashi Takamura, Miyuki Harada, Tetsuya Hirata, Yasushi Hirota, Osamu Wada‐Hiraike, Yutaka Osuga	3
10	Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study 2022 ·BMC Women s Health ·Aya Ishizaka, Ayumi Taguchi, Tetsushi Tsuruga, (unknown), Akira Kawata, Yuichiro Miyamoto, Michihiro Tanikawa, Masako Ikemura, Kenbun Sone, Mayuyo Mori, Kaori Koga, Tetsuo Ushiku, Katsutoshi Oda, Yutaka Osuga	7
11	Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022 ·Scientific Reports ·(unknown), Kaori Koga, Takehiro Hiraoka, Keiichi Kumasawa, (unknown), (unknown), Ayumi Taguchi, Tomoko Makabe, Arisa Takeuchi, Gentaro Izumi, Masashi Takamura, Miyuki Harada, Tetsuya Hirata, Yasushi Hirota, Osamu Wada‐Hiraike, Yutaka Osuga	4
12	Suppression of human trophoblast syncytialization by human cytomegalovirus infection 2021 ·Placenta ·(unknown), Takeshi Nagamatsu, Kazuki Morita, Ayumi Taguchi, Takashi Toya, Keiichi Kumasawa, Takayuki Iriyama, Kei Kawana, Naoki Inoue, Tomoyuki Fujii, Yutaka Osuga	13
13	The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis 2021 ·Journal of Reproductive Immunology ·(unknown), Kaori Koga, Masashi Takamura, Gentaro Izumi, (unknown), Ayumi Taguchi, Tomoko Makabe, Arisa Takeuchi, Miyuki Harada, Tetsuya Hirata, Yasushi Hirota, Osamu Wada‐Hiraike, Yutaka Osuga	8
14	History of whole pelvis plus para-aortic radiation is a risk factor associated with febrile neutropenia during chemotherapy for recurrent cervical cancer 2021 ·International Journal of Clinical Oncology ·(unknown), Ayumi Taguchi, (unknown), Yuichiro Miyamoto, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Tetsushi Tsuruga, Takehito Yamamoto, (unknown), Tappei Takada, Yutaka Osuga, Hiroshi Suzuki	1
15	Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation 2020 ·Blood Advances ·Satoshi Kaito, Y. Nakajima, Konan Hara, Takashi Toya, Tetsuya Nishida, Naoyuki Uchida, (unknown), Takahiro Fukuda, Yukiyasu Ozawa, Masatsugu Tanaka, Kazuhiro Ikegame, Yuta Katayama, Takuro Kuriyama, Junya Kanda, Yoshiko Atsuta, Masao Ogata, Ayumi Taguchi, Kazuteru Ohashi	19
16	Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia 2020 ·Virology Journal ·S. Baba, Ayumi Taguchi, Akira Kawata, Konan Hara, Satoko Eguchi, Mayuyo Mori, Katsuyuki Adachi, Seiichiro Mori, Takashi Iwata, Akira Mitsuhashi, Daichi Maeda, Atsushi Komatsu, Takeshi Nagamatsu, Katsutoshi Oda, Iwao Kukimoto, Yutaka Osuga, Tomoyuki Fujii, Kei Kawana	9
17	The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway 2018 ·BMC Cancer ·(unknown), Ayumi Taguchi, Akira Kawata, Kei Kawana, Mitsuyo Yoshida, Yuki Yoshimatsu, Masakazu Sato, Hiroe Nakamura, (unknown), (unknown), Asaha Fujimoto, Kensuke Tomio, Katsuyuki Adachi, Takeshi Nagamatsu, Katsutoshi Oda, Tohru Kiyono, Yutaka Osuga, Tomoyuki Fujii	17
18	Intracellular signaling entropy can be a biomarker for predicting the development of cervical intraepithelial neoplasia 2017 ·PLoS ONE ·Masakazu Sato, Kei Kawana, Katsuyuki Adachi, Asaha Fujimoto, Mitsuyo Yoshida, Hiroe Nakamura, Haruka Nishida, Tomoko Inoue, Ayumi Taguchi, (unknown), Satoko Eguchi, Aki Yamashita, Kensuke Tomio, Osamu Wada‐Hiraike, Katsutoshi Oda, Takeshi Nagamatsu, Yutaka Osuga, Tomoyuki Fujii	3
19	Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo 2014 ·PLoS ONE ·Ayumi Taguchi, Kei Kawana, Kensuke Tomio, Aki Yamashita, Yosuke Isobe, Kazunori Nagasaka, Kaori Koga, Tomoko Inoue, Haruka Nishida, Satoko Kojima, Katsuyuki Adachi, Yōko Matsumoto, Takahide Arimoto, Osamu Wada‐Hiraike, Katsutoshi Oda, Jing X. Kang, Hiroyuki Arai, Makoto Arita, Yutaka Osuga, Tomoyuki Fujii	60
20	Omega-3 Polyunsaturated Fatty Acids Suppress the Cystic Lesion Formation of Peritoneal Endometriosis in Transgenic Mouse Models 2013 ·PLoS ONE ·Kensuke Tomio, Kei Kawana, Ayumi Taguchi, Yosuke Isobe, Ryo Iwamoto, Aki Yamashita, Satoko Kojima, Mayuyo Mori, Takeshi Nagamatsu, Takahide Arimoto, Katsutoshi Oda, Yutaka Osuga, Yuji Taketani, Jing X. Kang, Hiroyuki Arai, Makoto Arita, Shiro Kōzuma, Tomoyuki Fujii	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact